Company / Capital Returned to Shareholders per Share
Edwards Lifesciences Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.54
FY2025
5-year range
$0.82 / $2.84
FY2021-FY2025
Trend
-20.2%
vs FY2024
Sector context
#52 of 108
Health Care
What the data says
At $1.54, Edwards Lifesciences's capital returned to shareholders per share ranks #52 of 108 in the Health Care sector. Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $0.82 in FY2021 to $3.83 in FY2018.
Based on SEC 10-K filings.
1.54 in FY2025 with a 5-year CAGR of +9.0%.
Improved from $0.84 to $1.54 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -18.5%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
-68.9% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share decreased 20.2% year-over-year.
- Ranks #52 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2018.
- Lowest capital returned to shareholders per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.54 | -20.2% |
| FY2024 | $1.93 | +128.8% |
| FY2023 | $0.84 | -70.3% |
| FY2022 | $2.84 | +245.5% |
| FY2021 | $0.82 | -18.0% |
| FY2020 | $1.00 | -20.4% |
| FY2019 | $1.26 | -67.1% |
| FY2018 | $3.83 | +6.2% |
| FY2017 | $3.61 | +15.2% |
| FY2016 | $3.13 | +20.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026